Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights Into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor

Drug Metabolism and Disposition - United States
doi 10.1124/dmd.115.069203
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)


Related search